Cite
Dasen B, Vlajnic T, Mengus C, et al. T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance. J Pathol Clin Res. 2016;3(1):44-57doi: 10.1002/cjp2.61.
Dasen, B., Vlajnic, T., Mengus, C., Ruiz, C., Bubendorf, L., Spagnoli, G., Wyler, S., Erne, P., Resink, T. J., & Philippova, M. (2017). T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance. The journal of pathology. Clinical research, 3(1), 44-57. https://doi.org/10.1002/cjp2.61
Dasen, Boris, et al. "T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance." The journal of pathology. Clinical research vol. 3,1 (2017): 44-57. doi: https://doi.org/10.1002/cjp2.61
Dasen B, Vlajnic T, Mengus C, Ruiz C, Bubendorf L, Spagnoli G, Wyler S, Erne P, Resink TJ, Philippova M. T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance. J Pathol Clin Res. 2016 Nov 26;3(1):44-57. doi: 10.1002/cjp2.61. eCollection 2017 Jan. PMID: 28138401; PMCID: PMC5259566.
Copy
Download .nbib